Mark Fishman (born February 1951) is a board-certified American cardiologist and researcher in Cambridge, Massachusetts. He previously served as the president of the Novartis Institutes for BioMedical Research (NIBR), the main research arm of Novartis Pharmaceuticals.
Mark Fishman Facts
- Full Name: Mark Charles Fishman
- Age: 71 years old
- Date of Birth: February 1951
- Occupation: Cardiologist
- Nationality: American
Mark Fishman Medical School & Residency
- Massachusetts General Hospital – Residency, Internal Medicine, 1982-1982
- Massachusetts General Hospital – Residency, Internal Medicine, 1976-1979
- Harvard Medical School – Medical School
Mark Fishman Career
Fishman served as a professor of medicine at Harvard Medical School, as chief of cardiology at Massachusetts General Hospital, and as director of the Cardiovascular Research Center at Massachusetts General Hospital.
He belongs to the National Academy of Sciences’ Institute of Medicine and is a fellow of the National Academy of Arts and Sciences. He chose to retire in 2016 after serving as the CEO of Novartis for 13 years.
Certifications & Licensure
- American Board of Internal Medicine – Certified in Internal Medicine
- MA State Medical License – Active through 2023
- Massachusetts General Hospital Boston, MA
Location & Contact Information
Data provided by the National Library of Medicine
- Cardiomyopathy in zebrafish due to mutation in an alternatively spliced exon of titin.
- Patterning of angiogenesis in the zebrafish embryo.
- Endothelial signaling in kidney morphogenesis: a role for hemodynamic forces.
- Disruption of acvrl1 increases endothelial cell number in zebrafish cranial vessels.
- From Zebrafish to human: modular medical models.
- The heartstrings mutation in zebrafish causes heart/fin Tbx5 deficiency syndrome.
- Cardiovascular system.
- The limb identity gene Tbx5 promotes limb initiation by interacting with Wnt2b and Fgf10.
- Nil per os encodes a conserved RNA recognition motif protein required for morphogenesis and cytodifferentiation of digestive organs in zebrafish.
- heart of glass regulates the concentric growth of the heart in zebrafish.
- Chemical suppression of a genetic mutation in a zebrafish model of aortic coarctation.
- Mark C. Fishman.
- Discovery and use of small molecules for probing biological processes in zebrafish.
- VEGF-PLCgamma1 pathway controls cardiac contractility in the embryonic heart.
- Pharmaceuticals: a new grammar for drug discovery
Mark Fishman Net Worth
Mark Fishman had an estimated net worth of,$5 million.